Piper Sandler Reiterates Overweight Rating on OrthoPediatrics, Sets $30 Target
Piper Sandler reiterated its Overweight rating and $30 price target on OrthoPediatrics. The target implies 25.9% upside from the Oct. 27 close of $23.82.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Piper Sandler reiterated its Overweight rating and $30 price target on OrthoPediatrics. The target implies 25.9% upside from the Oct. 27 close of $23.82.